National Institute of Allergy and Infectious Diseases (NIAID) Researcher Updates Knowledge of Remdesivir (SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir)

Press/Media

Period13 May 2024

Media coverage

1

Media coverage

  • TitleNational Institute of Allergy and Infectious Diseases (NIAID) Researcher Updates Knowledge of Remdesivir (SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir)
    Media name/outletNewsRx COVID-19 Daily
    Country/TerritoryUnited States
    Date13/05/24
    PersonsRhonda Colombo